Biology and technology are becoming more closely intertwined, with opportunities emerging to improve healthcare through innovative digital technologies and dramatically impacting on the health and wellness of people.

With the patient at the heart of it, at this year’s Life Science Forum we discuss productivity in big pharma, connecting big pharma with future technologies, how the life science venture model has changed, and where the investment dollars are heading. Listen to Leif Johansson, Non-Executive Chairman of AstraZeneca and other leading industry speakers. Find out more about the programme here. 

Date: 14 November 2019
Timings: 6:30-9:00pm
Venue: Deutsche Bank, 1 Great Winchester Street, London EC2N 2DB

Audience: Whilst targeting the life sciences community – pharma, biotech, venture, investment, academics – we welcome the broader Swedish-British business community to participate.

Booking information:
One Nucleus member price: £45
Non-member price: £135